Invention Grant
- Patent Title: Pharmaceutical composition for treatment of or remission in elderly or terminal cancer patient
-
Application No.: US15536952Application Date: 2015-11-25
-
Publication No.: US10293019B2Publication Date: 2019-05-21
- Inventor: Hiromi Wada
- Applicant: DELTA-FLY PHARMA, INC.
- Applicant Address: JP Tokushima-Shi, Tokushima
- Assignee: DELTA-FLY PHARMA, INC.
- Current Assignee: DELTA-FLY PHARMA, INC.
- Current Assignee Address: JP Tokushima-Shi, Tokushima
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- Priority: JP2014-255403 20141217
- International Application: PCT/JP2015/083119 WO 20151125
- International Announcement: WO2016/098546 WO 20160623
- Main IPC: A61K38/05
- IPC: A61K38/05 ; A61K38/55 ; A61K45/00 ; A61K45/06 ; A61P35/04
Abstract:
An object of the present invention is to provide a novel treatment method with fewer side effects for elderly cancer patients and terminal cancer patients. A pharmaceutical composition for treating or putting an elderly or a terminal cancer patient into remission, comprising, as an active ingredient, (2S)-2-[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoylamino]-4-methylpentanoic acid or a pharmacologically acceptable salt thereof.
Public/Granted literature
- US20180256668A1 PHARMACEUTICAL COMPOSITION FOR TREATMENT OF OR REMISSION IN ELDERLY OR TERMINAL CANCER PATIENT Public/Granted day:2018-09-13
Information query
IPC分类:
